Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.75 GBX | -5.41% | -7.89% | -6.42% |
Sales 2023 * | 11.15M 13.85M | Sales 2024 * | 15.59M 19.37M | Capitalization | 28.6M 35.53M |
---|---|---|---|---|---|
Net income 2023 * | -3M -3.73M | Net income 2024 * | - 0 | EV / Sales 2023 * | 2.83 x |
Net Debt 2023 * | 3M 3.73M | Net Debt 2024 * | 2.5M 3.11M | EV / Sales 2024 * | 1.99 x |
P/E ratio 2023 * |
-9.31
x | P/E ratio 2024 * |
-
| Employees | 65 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.71% |
1 day | -5.41% | ||
1 week | -7.89% | ||
Current month | -7.89% | ||
1 month | -10.26% | ||
3 months | -4.11% | ||
6 months | -12.50% | ||
Current year | -6.42% |
Managers | Title | Age | Since |
---|---|---|---|
Stuart Gall
CEO | Chief Executive Officer | 62 | - |
Helen Jones
DFI | Director of Finance/CFO | - | 19-12-31 |
Kathryn Jenner
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 77 | 11-12-31 | |
Stuart Gall
CEO | Chief Executive Officer | 62 | - |
Director/Board Member | 40 | 21-05-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 8.75 | -5.41% | 49,852 |
24-04-17 | 9.25 | 0.00% | 51,409 |
24-04-16 | 9.25 | -2.63% | 15,250 |
24-04-15 | 9.5 | -5.00% | 401,035 |
24-04-12 | 10 | +5.26% | 50,045 |
Delayed Quote London S.E., April 18, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.42% | 37.64M | |
-17.67% | 2.9B | |
-36.52% | 2.22B | |
+28.43% | 1.71B | |
-26.90% | 1.46B | |
+20.34% | 818M | |
+2.79% | 815M | |
-.--% | 813M | |
+26.20% | 803M | |
+13.66% | 767M |
- Stock Market
- Equities
- MED Stock